News

Northern VCTs Launch New Investment Opportunity for Shareholders

Northern VCTs Launch New Investment Opportunity for Shareholders

Introduction to the Northern 3 VCT PLC

Northern 3 VCT PLC is making headlines as it announces a new opportunity for investors. This update highlights the publication of a prospectus, allowing investors to participate in exciting new offers of ordinary shares for the 2025/26 tax year.

Details of the Investment Offers

In collaboration with Northern Venture Trust PLC and Northern 2 VCT PLC, collectively known as the Northern VCTs, the company seeks to raise substantial funding through these offers. The goal is to secure a total of £14 million for both Northern 3 VCT PLC and Northern Venture Trust PLC, while Northern 2 VCT PLC aims for £7 million. Additionally, there are provisions for over-allotment facilities, which could raise an additional £6 million for the former two companies and £3 million for the latter.

Application Process and Shareholder Benefits

The application process for these shares will commence at 8:00 AM on a specified date. The offers will be accepted on a first-come, first-served basis. Existing shareholders as of a specific date will receive a 0.5% discount on offer costs if their applications are accepted. This move is a token of appreciation for their loyalty, enhancing the attractiveness of the investment opportunity.

Key Dates and Allotment Information

Investors can note that the offers are expected to remain open until noon on a specified date, unless oversubscribed sooner. The first allotment of shares will occur shortly after a designated date, with detailed instructions on application submissions provided to ensure potential investors do not miss out.

Role and Compensation of the Investment Manager

Mercia Fund Management Limited plays a crucial role as the investment adviser and promoter for the Northern VCTs. According to the arrangements, Mercia will receive a promoter's fee of up to 5.5% of the total subscription amounts received, with an annual commission applicable for five years based on the gross funds subscribed. This financial structure emphasizes the company's commitment to managing its investments efficiently while keeping its shareholders in mind.

Fairness and Compliance Considerations

As the investment manager, Mercia is recognized as a related party under the UK's Listing Rules. The board asserts that the arrangements made are fair and reasonable for shareholders, backed by written confirmation from a corporate services firm acting on behalf of the Company. This step is essential for maintaining transparency and compliance with financial regulations.

Accessing the Prospectus and Investment Brochure

For those eager to learn more about the offers, a downloadable version of the prospectus is readily available. This document contains detailed information and is essential for potential applicants looking to participate in this investment opportunity.

Contact Information and Support

Potential investors or interested parties can easily reach out for inquiries regarding these offers. The dedicated customer support team at Mercia Fund Management Limited is available to assist with any questions. A website that houses more information about the investment offerings is also accessible to enhance shareholders' knowledge.

Frequently Asked Questions

What is the purpose of the prospectus published by Northern 3 VCT PLC?

The prospectus outlines the offers of new ordinary shares for subscription, aiming to raise funds for the company's upcoming fiscal year.

Who can benefit from the offers provided by the Northern VCTs?

Existing shareholders of the Northern VCTs as of a specified date, alongside their spouses or civil partners, can take advantage of the reduced offer costs.

How will the application process work for interested investors?

Applications can be submitted starting from a specific time and will be processed on a first-come, first-served basis until a closing date, provided shares remain available.

What role does Mercia Fund Management Limited play?

Mercia acts as the investment adviser and promoter for the Northern VCTs, entitled to receive a fee based on the funding raised through the offers.

Where can I find more information about the investment opportunities?

The prospectus, along with an investment brochure, can be accessed via the company's website and by contacting their support team directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading